Valve Disease. Valve Surgery. In 2015, Cleveland Clinic surgeons performed 2943 valve surgeries.

Size: px
Start display at page:

Download "Valve Disease. Valve Surgery. In 2015, Cleveland Clinic surgeons performed 2943 valve surgeries."

Transcription

1 Valve Surgery Volume N = In 15, surgeons performed 93 valve surgeries. surgeons have implanted more than 1,5 bioprosthetic aortic valves since the 199s, with excellent short- and long-term outcomes. Outcomes 15

2 Primary Operation and Reoperation Volume (N = 93) 15 Volume Primary Operation Reoperation surgeons performed 93 valve procedures in 15. A total of 199 were primary operations and 7 were reoperations (5%). Primary Operation and Reoperation In-Hospital Mortality (N = 93) 15 Primary Operation Reoperation Patients who have valve surgery reoperations have a somewhat higher risk of death compared with patients who have a primary operation, due to the overall decrease in health over time. Despite this, the in-hospital mortality rates were lower than expected for both reoperations and primary procedures. Source: Data from the Vizient Clinical Data Base/Resource Manager TM used by permission of Vizient. All rights reserved. Sydell and Arnold Miller Family Heart & Vascular Institute 9

3 In-Hospital Mortality by Type (N = 93) Surgical Isolated AVR Transcatheter AVR AVR + CABG % Isolated MVR % % MVR + CABG Isolated MV Repair Septal Myectomy a N = STS expected The 15 in-hospital mortality rates for all types of valve surgery at were lower than expected. AVR = aortic valve replacement, CABG = coronary artery bypass grafting, MV = mitral valve, MVR = mitral valve replacement a These valve surgery cases do not have established STS expected mortality rates due to the complexity of the procedures. Source: Society of Thoracic Surgeons (STS) National Adult Cardiac Surgery Database 15 Aortic Valve Surgery Volume 15 In 15, 193 aortic valve procedures were performed at. 1 5 N = Outcomes 15 3

4 STS Rating for Aortic Valve Replacement June 1 June 15 ranked among the top % of US hospitals for aortic valve replacement (AVR) surgery, earning the Society of Thoracic Surgeons (STS) 3-star rating for this category. This denotes the highest category of quality. Participant Score (95% Confidence Interval) STS Mean Participant Score Participant Rating 97.% 9.7% (9., 97.9) STS Min.3 1th 9.1 5th th 97. Max 9.5 = STS mean participant score Source: Society of Thoracic Surgeons (STS) National Adult Cardiac Surgery Database 15 Isolated Aortic Valve Replacement Complications (N = ) 15 1 STS expected % Deep Sternal Wound Infection Postop Stroke Postop Renal Failure Postop Reoperation (Any) had lower-than-expected rates of complications for isolated aortic valve replacement surgery. Source: Society of Thoracic Surgeons (STS) National Adult Cardiac Surgery Database 15 Sydell and Arnold Miller Family Heart & Vascular Institute 31

5 STS Rating for Coronary Artery Bypass Grafting and Aortic Valve Replacement June 1 June 15 ranked among the top.3% of US hospitals for coronary artery bypass graft (CABG) surgery plus aortic valve replacement (AVR), earning the Society of Thoracic Surgeons (STS) 3-star rating for this category (based on data from July 1 through June 15). This denotes the highest category of quality. Participant Score (95% Confidence Interval) STS Mean Participant Score Participant Rating 95.5% 91.7% (9., 9.3) STS Min 79. 1th.3 5th 9.1 9th 9.7 Max 97.1 = STS mean participant score Source: Society of Thoracic Surgeons (STS) National Adult Cardiac Surgery Database 15 Combined Coronary Artery Bypass Grafting and Aortic Valve Replacement In-Hospital Mortality (N = 1) 15 1 N = Primary Operation 1 Reoperation 3 STS expected Source: Society of Thoracic Surgeons (STS) National Adult Cardiac Surgery Database 15 Aortic valve replacement, in combination with coronary artery bypass graft (CABG) surgery, is a complex operation. Despite this complexity and the associated increase in risks, in-hospital mortality rates for both primary operations and reoperations were low. 3 Outcomes 15

6 Mitral Valve Surgery Volume, Repair vs Replacement Repair Replacement performs mitral valve repair procedures rather than replacement whenever possible. Mitral valve repair is associated with better survival, improved lifestyle, better preservation of heart function, and a lower risk of stroke and infection (endocarditis) compared with mitral valve replacement. Repair procedures also do not require postprocedure anticoagulation therapy. Isolated Mitral Valve Surgery In-Hospital Mortality (N = 13) 15 STS expected The 15 in-hospital mortality rates for patients who had isolated mitral valve surgery were lower than expected for both repair and replacement procedures. % Replacement Repair N = 9 3 Source: Society of Thoracic Surgeons (STS) National Adult Cardiac Surgery Database 15 As world leaders in mitral valve repairs, surgeons performed robotically assisted mitral valve surgery on 1 patients from to 1. The mortality rate was.1% (N = 1). Source: Gillinov AM, Mihaljevic T, Javadikasgari H, Suri R, Mick S, Navia J, Desai M, Bonatti J, Khosravi M, Idrees J, Lowry A, Blackstone E, Svensson L. Safety and Effectiveness of Robotically Assisted Mitral Valve Surgery: Analysis of 1, Consecutive Cases. Paper presented at: American Association for Thoracic Surgery Annual Meeting; May 1-1, 1. Baltimore, MD. Sydell and Arnold Miller Family Heart & Vascular Institute 33

7 Surgical Treatment of Active Infective Endocarditis Primary Operation, In-Hospital Mortality Observed The in-hospital mortality rates for patients who had primary operations for infective endocarditis were lower than expected in N = % Source: Data from the Vizient Clinical Data Base/Resource Manager TM used by permission of Vizient. All rights reserved. Reoperation, In-Hospital Mortality Observed The in-hospital mortality rates for patients who had reoperations for infective endocarditis were lower than expected in N = Source: Data from the Vizient Clinical Data Base/Resource Manager TM used by permission of Vizient. All rights reserved. 3 Outcomes 15

8 Transcatheter Aortic Valve Replacement is a national leader in the use of percutaneous treatment options for patients with valve disease. Volume and In-Hospital Mortality Volume N = Mortality (%) 1 1 Observed N = A total of 33 patients had transcatheter aortic valve replacement (TAVR) procedures at in 15. The in-hospital mortality rate was.3% compared with an expected rate of 7.%. Source: Data from the Vizient Clinical Data Base/Resource Manager TM used by permission of Vizient. All rights reserved. Since the inception of the transcatheter aortic valve replacement (TAVR) program in, has become a world leader in the use of this specialized treatment in patients carefully selected based upon stringent clinical criteria. A total of 1 patients have had this procedure done from 1 to 15, and the in-hospital mortality rate was 1.7% compared with the expected rate of 7.7%. Source: STS/ACC TVT Registry Sydell and Arnold Miller Family Heart & Vascular Institute 35

9 In-Hospital Mortality (N = 1) 1 15 began its transcatheter aortic valve replacement (TAVR) program in. From 1 to 15, 1 TAVR procedures have been performed with a lower-than-expected mortality rate (1.7% vs 7.7%). Source: Society of Thoracic Surgeons (STS)/American College of Cardiology (ACC) Transcatheter Valve Therapy (TVT) Registry Volume by Approach (N = 75) 1 15 Of the 75 TAVR procedures performed from 1 through 15, 73% have been done using a transfemoral approach. 1% 73% transfemoral (N = 39) 17% transapical (N = 1) 7% transaortic (N = 3) % other (transaxillary, transcarotid) (N = 15) 1% subclavian (N = 1) 3 Outcomes 15

Valve Disease. Valve Surgery. Total Volume. In 2016, Cleveland Clinic surgeons performed 3039 valve surgeries.

Valve Disease. Valve Surgery. Total Volume. In 2016, Cleveland Clinic surgeons performed 3039 valve surgeries. Valve Surgery Total Volume 1 1 Volume 35 3 5 15 1 5 1 13 1 N = 773 5 79 15 93 1 339 In 1, surgeons performed 339 valve surgeries. surgeons have implanted more than 1, bioprosthetic aortic valves since

More information

Ischemic Heart Disease Interventional Treatment

Ischemic Heart Disease Interventional Treatment Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 89) is a regional and national referral center for percutaneous coronary intervention (PCI). A total of

More information

Ischemic Heart Disease Interventional Treatment

Ischemic Heart Disease Interventional Treatment Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 11,61) is a regional and national referral center for percutaneous coronary intervention (PCI). A total

More information

Policy Specific Section: March 30, 2012 March 7, 2013

Policy Specific Section: March 30, 2012 March 7, 2013 Medical Policy Transcatheter Aortic Valve Replacement for Aortic Stenosis Type: Medical Necessity and Investigational / Experimental Policy Specific Section: Surgery Original Policy Date: Effective Date:

More information

Mechanical vs. Bioprosthetic Aortic Valve Replacement: Time to Reconsider? Christian Shults, MD Cardiac Surgeon, Medstar Heart and Vascular Institute

Mechanical vs. Bioprosthetic Aortic Valve Replacement: Time to Reconsider? Christian Shults, MD Cardiac Surgeon, Medstar Heart and Vascular Institute Mechanical vs. Bioprosthetic Aortic Valve Replacement: Time to Reconsider? Christian Shults, MD Cardiac Surgeon, Medstar Heart and Vascular Institute Assistant Professor, Georgetown School of Medicine

More information

In 2015, Cleveland Clinic surgeons performed 1551 thoracic procedures. The in-hospital mortality rate was 2.1%. 20% airway (N = 315)

In 2015, Cleveland Clinic surgeons performed 1551 thoracic procedures. The in-hospital mortality rate was 2.1%. 20% airway (N = 315) thoracic surgeons treat patients with a wide variety of diseases of the lung and esophagus. The staff is composed of specialists in lung and esophageal cancer, lung failure, airway disease, swallowing

More information

After PARTNER 2A/S3i and SURTAVI: What is the Role of Surgery in Intermediate-Risk AS Patients?

After PARTNER 2A/S3i and SURTAVI: What is the Role of Surgery in Intermediate-Risk AS Patients? After PARTNER 2A/S3i and SURTAVI: What is the Role of Surgery in Intermediate-Risk AS Patients? Vinod H. Thourani, MD Professor of Surgery and Medicine Emory University Disclosure Statement of Financial

More information

Peripheral Vascular Disease

Peripheral Vascular Disease Peripheral artery disease (PAD) results from the buildup of plaque (atherosclerosis) in the arteries of the legs. For people with PAD, symptoms may be mild, requiring no treatment except modification of

More information

In Process, Unpublished STS/ACC TVT Registry Manuscripts

In Process, Unpublished STS/ACC TVT Registry Manuscripts In Process, Unpublished STS/ACC TVT Registry Manuscripts The following pages list current research and publications proposals that have been recently approved, are under analysis, are under manuscript

More information

In Process, Unpublished STS/ACC TVT Registry Manuscripts

In Process, Unpublished STS/ACC TVT Registry Manuscripts In Process, Unpublished STS/ACC TVT Registry Manuscripts The following pages list current research and publications proposals that have been recently approved, are under analysis, are under manuscript

More information

Aortic Disease. Aortic Surgery

Aortic Disease. Aortic Surgery The Aorta Center in Cleveland Clinic s Heart & Vascular Institute is organized to optimize the care of patients and to facilitate collaboration across disciplines with a focus on conditions that affect

More information

Valvular Intervention

Valvular Intervention Valvular Intervention Outline Introduction Aortic Stenosis Mitral Regurgitation Conclusion Calcific Aortic Stenosis Deformed Eccentric Calcified Nodular Rigid HOSTILE TARGET difficult to displace prone

More information

Valvular Heart Disease Transcatheter Valve Therapies. October 2016 Brian Whisenant MD

Valvular Heart Disease Transcatheter Valve Therapies. October 2016 Brian Whisenant MD Valvular Heart Disease Transcatheter Valve Therapies October 2016 Brian Whisenant MD Disclosure Statement of Financial Interest Within the past 12 months, I or my spouse/partner have had a financial interest/arrangement

More information

Outcomes in the Commercial Use of Self-expanding Prostheses in Transcatheter Aortic Valve Replacement: A Comparison of the Medtronic CoreValve and

Outcomes in the Commercial Use of Self-expanding Prostheses in Transcatheter Aortic Valve Replacement: A Comparison of the Medtronic CoreValve and Outcomes in the Commercial Use of Self-expanding Prostheses in Transcatheter Aortic Valve Replacement: A Comparison of the Medtronic CoreValve and Evolut R platforms in the Society of Thoracic Surgeons/American

More information

Transcatheter Valve Replacement: Current State in 2017

Transcatheter Valve Replacement: Current State in 2017 Transcatheter Valve Replacement: Current State in 2017 Marc A. Sintek MD Assistant Professor of Medicine Interventional Cardiology Cardiovascular Division Washington University in St. Louis Missouri ACP

More information

Appropriate Patient Selection or Healthcare Rationing? Lessons from Surgical Aortic Valve Replacement in The PARTNER I Trial Wilson Y.

Appropriate Patient Selection or Healthcare Rationing? Lessons from Surgical Aortic Valve Replacement in The PARTNER I Trial Wilson Y. Appropriate Patient Selection or Healthcare Rationing? Lessons from Surgical Aortic Valve Replacement in The PARTNER I Trial Wilson Y. Szeto, MD on behalf of The PARTNER Trial Investigators and The PARTNER

More information

Contemporary outcomes for surgical mitral valve repair: A benchmark for evaluating emerging mitral valve technology

Contemporary outcomes for surgical mitral valve repair: A benchmark for evaluating emerging mitral valve technology Contemporary outcomes for surgical mitral valve repair: A benchmark for evaluating emerging mitral valve technology Damien J. LaPar, MD, MSc, Daniel P. Mulloy, MD, Ivan K. Crosby, MBBS, D. Scott Lim, MD,

More information

THE VALVE CLINIC VALVE CONFERENCE

THE VALVE CLINIC VALVE CONFERENCE VALVE CLINIC THE VALVE CLINIC Houston Methodist DeBakey Valve Clinic combines outstanding clinical care, advanced imaging and surgical excellence to offer coordinated evaluation and treatment options for

More information

Sotirios N. Prapas, M.D., Ph.D, F.E.C.T.S.

Sotirios N. Prapas, M.D., Ph.D, F.E.C.T.S. CORONARY ARTERY REVASCULARIZATION WITH MILD AORTIC STENOSIS: STRATEGIES OF TREATMENT 9 th ANNUAL MEETING OF THE EAB SOCIETY, Pravets, Bulgaria, 2012 Sotirios N. Prapas, M.D., Ph.D, F.E.C.T.S. Director

More information

MitraClip: Why, How, and For Whom?

MitraClip: Why, How, and For Whom? MitraClip: Why, How, and For Whom? Robert O. Bonow, MD, MS Northwestern University Feinberg School of Medicine Bluhm Cardiovascular Institute Northwestern Memorial Hospital Editor-in-Chief, JAMA Cardiology

More information

MINIMALLY INVASIVE MITRAL VALVE SURGERY. Rohinton J. Morris, MD Chief, Cardiothoracic Surgery Jefferson University and Health Systems

MINIMALLY INVASIVE MITRAL VALVE SURGERY. Rohinton J. Morris, MD Chief, Cardiothoracic Surgery Jefferson University and Health Systems MINIMALLY INVASIVE MITRAL VALVE SURGERY Rohinton J. Morris, MD Chief, Cardiothoracic Surgery Jefferson University and Health Systems OVERVIEW History Anatomy Indications Techniques Variants Outcomes &

More information

Is a minimally invasive approach for re-operative aortic valve replacement superior to standard full resternotomy?

Is a minimally invasive approach for re-operative aortic valve replacement superior to standard full resternotomy? Interactive CardioVascular and Thoracic Surgery Advance Access published May 7, 2012 Interactive CardioVascular and Thoracic Surgery 0 (2012) 1 5 doi:10.1093/icvts/ivr141 BEST EVIDENCE TOPIC Is a minimally

More information

Hardware in the Chest - From VADs to Valves

Hardware in the Chest - From VADs to Valves Hardware in the Chest - From VADs to Valves Cristina Fuss, MD Purpose Recognize the device Indication and function Cristina Fuss, MD Department of Diagnostic Radiology FROM VADS TO VALVES Implanting technique

More information

Extension to medium and low risk patients? Friedrich Eckstein University Hospital Basel

Extension to medium and low risk patients? Friedrich Eckstein University Hospital Basel TAVI CON Extension to medium and low risk patients? Friedrich Eckstein University Hospital Basel Extension to medium and low risk patients? In octogenerians already reality in most of the swiss clinics!?

More information

CIPG Transcatheter Aortic Valve Replacement- When Is Less, More?

CIPG Transcatheter Aortic Valve Replacement- When Is Less, More? CIPG 2013 Transcatheter Aortic Valve Replacement- When Is Less, More? James D. Rossen, M.D. Professor of Medicine and Neurosurgery Director, Cardiac Catheterization Laboratory and Interventional Cardiology

More information

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome Measure #165 (NQF 0130): Coronary Artery Bypass Graft (CABG): Deep Sternal Wound Infection Rate National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY

More information

Heart & Vascular Institute Outcomes

Heart & Vascular Institute Outcomes Heart & Vascular Institute & 2013 Outcomes Measuring Outcomes Promotes Quality Improvement Measuring and understanding outcomes of medical treatments promotes quality improvement. Cleveland Clinic has

More information

Tissue vs Mechanical What s the Data??

Tissue vs Mechanical What s the Data?? Biological (Tissue) Valve in a 60 year old patient: Debate Tissue vs Mechanical What s the Data?? Joseph E. Bavaria, MD Immediate-Past President - Society of Thoracic Surgeons (STS) Brooke Roberts-William

More information

Objectives. Describe a multidisciplinary team and it s utilization in the inpatient cardiovascular surgical patient

Objectives. Describe a multidisciplinary team and it s utilization in the inpatient cardiovascular surgical patient None Endorsements Objectives Describe a multidisciplinary team and it s utilization in the inpatient cardiovascular surgical patient Understand clinical and clinician benefits of a multidisciplinary team

More information

TAVI and TAVR: Radical and Revolutionary: The Newest Insights for the CV Community and a Panel Discussion

TAVI and TAVR: Radical and Revolutionary: The Newest Insights for the CV Community and a Panel Discussion TAVI and TAVR: Radical and Revolutionary: The Newest Insights for the CV Community and a Panel Discussion Moderator: Joseph E. Bavaria, MD Roberts-Measey Professor of Surgery Vice Chair, Division of Cardiovascular

More information

What is the Role of Surgical Repair in 2012

What is the Role of Surgical Repair in 2012 What is the Role of Surgical Repair in 2012 The Long-Term Results of Surgery Raphael Rosenhek Department of Cardiology Medical University of Vienna European Society of Cardiology 2012 Munich, August 27th

More information

2016 Physician Quality Reporting System Data Collection Form: Coronary Artery Bypass Graft (CABG) (for patients aged 18 years and older)

2016 Physician Quality Reporting System Data Collection Form: Coronary Artery Bypass Graft (CABG) (for patients aged 18 years and older) 2016 Physician Quality Reporting System Data Collection Form: Coronary Artery Bypass Graft (CABG) (for patients aged 18 years and older) IMPORTANT: Any measure with a 0% performance rate (100% for inverse

More information

Kinsing Ko, Thom de Kroon, Najim Kaoui, Bart van Putte, Nabil Saouti. St. Antonius Hospital, Nieuwegein, The Netherlands

Kinsing Ko, Thom de Kroon, Najim Kaoui, Bart van Putte, Nabil Saouti. St. Antonius Hospital, Nieuwegein, The Netherlands Minimal Invasive Mitral Valve Surgery After Previous Sternotomy Without Aortic Clamping: Short- and Long Term Results of a Single Surgeon Single Institution Kinsing Ko, Thom de Kroon, Najim Kaoui, Bart

More information

mm Porcine valve Patient had requested

mm Porcine valve Patient had requested Mrs CY Age 77 History 2000:Age 60: MVR 27mm St Jude Valve (severe MR) 2015:Age 75: Paravalvular mitral leak, haemolytic anaemia, tricuspid incompetence. 27mm Porcine valve and 29mm Duran ring tricuspid

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Ablation, radiofrequency, anesthetic considerations for, 479 489 Acute aortic syndrome, thoracic endovascular repair of, 457 462 aortic

More information

Surgeon Involvement in Transcatheter Valve Therapy

Surgeon Involvement in Transcatheter Valve Therapy Surgeon Involvement in Transcatheter Valve Therapy Prof. Hendrik Treede Mid-German Heartcenter University Hospital Halle (Saale) Once upon a time. classic interventional cardiology classic cardiac surgery

More information

The Ross Procedure: Outcomes at 20 Years

The Ross Procedure: Outcomes at 20 Years The Ross Procedure: Outcomes at 20 Years Tirone David Carolyn David Anna Woo Cedric Manlhiot University of Toronto Conflict of Interest None The Ross Procedure 1990 to 2004 212 patients: 66% 34% Mean age:

More information

Mitral Valve Surgery: Lessons from New York State

Mitral Valve Surgery: Lessons from New York State Mitral Valve Surgery: Lessons from New York State Joanna Chikwe, MD Professor of Cardiovascular Surgery Icahn School of Medicine at Mount Sinai Chairman & Program Director Department of Cardiovascular

More information

Transcatheter Therapies For Aortic Valve Disease. March 2017 Brian Whisenant MD

Transcatheter Therapies For Aortic Valve Disease. March 2017 Brian Whisenant MD Transcatheter Therapies For Aortic Valve Disease March 2017 Brian Whisenant MD Introduction I got into this field to protect my turf. I must say, I have come full circle... - Kent W. Jones I got into this

More information

Debate: SAVR for Low-Risk Patients in 2017 is Obsolete AVR vs TAVI

Debate: SAVR for Low-Risk Patients in 2017 is Obsolete AVR vs TAVI Debate: SAVR for Low-Risk Patients in 2017 is Obsolete AVR vs TAVI Joseph E. Bavaria, MD Roberts-Measey Professor of Surgery Vice Chair, Division of Cardiovascular Surgery University of Pennsylvania Immediate

More information

TAVR and Cardiac Surgeons

TAVR and Cardiac Surgeons TAVR and Cardiac Surgeons TAVR and Cardiac Surgeons Ragheb Hasan Consultant and Clinical Lead Cardiothoracic Surgeon Manchester Royal Infirmary, Oxford Road, Manchester UK Aortic Stenosis Is A Growing

More information

Late failure of transcatheter heart valves: An open question

Late failure of transcatheter heart valves: An open question Late failure of transcatheter heart valves: An open question A comparison with surgically implanted bioprosthetic heart valves. A. Rashid The Cardiothoracic Centre Liverpool, UK. Conflict of Interest Statement

More information

7 th Conference of Transcatheter Heart Valve Therapies

7 th Conference of Transcatheter Heart Valve Therapies 7 th Conference of Transcatheter Heart Valve Therapies May 18-19, 2018, Athens Hilton Athens, Greece Course Directors Stratis Pattakos MD Konstantinos Spargias MD Panos Vardas MD Co-Directors Nick Bouboulis

More information

THE NATIONAL QUALITY FORUM

THE NATIONAL QUALITY FORUM THE NATIONAL QUALITY FORUM National Voluntary Consensus Standards for Patient Outcomes Table of Measures Submitted-Phase 1 As of March 5, 2010 Note: This information is for personal and noncommercial use

More information

2/15/2018 DISCLOSURES OBJECTIVES. Consultant for BioSense Webster, a J&J Co. Aortic stenosis background. Short history of TAVR

2/15/2018 DISCLOSURES OBJECTIVES. Consultant for BioSense Webster, a J&J Co. Aortic stenosis background. Short history of TAVR TRANSCATHETER AORTIC VALVE REPLACEMENT IN 2018: IS IT NOW THE STANDARD OF CARE? 22 ND ANNUAL COASTAL CARDIAC & VASCULAR CONFERENCE FEBRUARY 17, 2018 R. David Anderson, MD, MS, FACC, FSCAI Professor of

More information

New Paradigms in Thoracic. Accommodate Advances in Cardiovascular Surgical Therapy. A.J. Carpenter, MD, PhD Professor of Thoracic Surgery

New Paradigms in Thoracic. Accommodate Advances in Cardiovascular Surgical Therapy. A.J. Carpenter, MD, PhD Professor of Thoracic Surgery New Paradigms in Thoracic Surgical Training to Accommodate Advances in Cardiovascular Surgical Therapy A.J. Carpenter, MD, PhD Professor of Thoracic Surgery University i of ftexas Health hscience Center,

More information

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome Measure #445 (NQF 0119): Risk-Adjusted Operative Mortality for Coronary Artery Bypass Graft (CABG) National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY

More information

Valvular Heart Disease and Adult Congenital Intervention. A Pichard, MD. Director Cath Labs, Washington Hospital Center. Georgetown University.

Valvular Heart Disease and Adult Congenital Intervention. A Pichard, MD. Director Cath Labs, Washington Hospital Center. Georgetown University. Valvular Heart Disease and Adult Congenital Intervention. A Pichard, MD Director Cath Labs, Washington Hospital Center. ProfessorofMedicine (Cardiology), Georgetown University. Conflict of Interest Proctor

More information

Igor Palacios, MD Director of Interventional Cardiology Massachusetts General Hospital Professor of Medicine Harvard Medical School

Igor Palacios, MD Director of Interventional Cardiology Massachusetts General Hospital Professor of Medicine Harvard Medical School Aortic Stenosis: Current State of Percutaneous Therapies, Emerging Technologies and Future Directions Igor Palacios, MD Director of Interventional Cardiology Massachusetts General Hospital Professor of

More information

DESCRIPTION: Percentage of patients aged 18 years and older undergoing isolated CABG surgery who received an IMA graft

DESCRIPTION: Percentage of patients aged 18 years and older undergoing isolated CABG surgery who received an IMA graft Measure #43 (NQF 0134): Coronary Artery Bypass Graft (CABG): Use of Internal Mammary Artery (IMA) in Patients with Isolated CABG Surgery National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS

More information

Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results

Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results Short Communication Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results Marco Russo, Guglielmo Saitto, Paolo Nardi, Fabio Bertoldo, Carlo Bassano, Antonio Scafuri,

More information

Measure #167 (NQF 0114): Coronary Artery Bypass Graft (CABG): Postoperative Renal Failure National Quality Strategy Domain: Effective Clinical Care

Measure #167 (NQF 0114): Coronary Artery Bypass Graft (CABG): Postoperative Renal Failure National Quality Strategy Domain: Effective Clinical Care Measure #167 (NQF 0114): Coronary Artery Bypass Graft (CABG): Postoperative Renal Failure National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE

More information

Surgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea

Surgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea Surgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea Contents Decision making in surgical AVR in old age Clinical results of AVR with tissue valve Impact of 19mm

More information

Strokes After TAVR Reasons for Declining Frequency

Strokes After TAVR Reasons for Declining Frequency Strokes After TAVR Reasons for Declining Frequency Samir Kapadia, MD Professor of Medicine Director, Cardiac Catheterization Laboratory Cleveland Clinic Disclosure NONE Second Generation Valves Newer

More information

Aortic Valve Stenosis and TAVR: Putting it all together.

Aortic Valve Stenosis and TAVR: Putting it all together. Aortic Valve Stenosis and TAVR: Putting it all together. Maria L. Held, MSN CNS Valve Clinic Coordinator at The Cleveland Clinic Alliance of Cardiovascular Professionals April 14 th, 2018 Brief Anatomy

More information

Percutaneous Transapical Access for Thoracic Endovascular Repair

Percutaneous Transapical Access for Thoracic Endovascular Repair Percutaneous Transapical Access for Thoracic Endovascular Repair Atman P. Shah MD FACC FSCAI Co-Director, Hans Hecht Cardiac Catheterization Laboratory Clinical Director, Section of Cardiology Associate

More information

Published Manuscripts Based in the STS/ACC TVT Registry

Published Manuscripts Based in the STS/ACC TVT Registry Published Manuscripts Based in the STS/ACC TVT Registry June 2018 Legend Manuscript Status is designated as follows: Abbreviations: Published/Full Citation Provided: Manuscript is in print. In Press: Manuscript

More information

Alec Vahanian,FESC, FRCP (Edin.) Bichat Hospital University Paris VII, Paris, France

Alec Vahanian,FESC, FRCP (Edin.) Bichat Hospital University Paris VII, Paris, France Future Percutaneous Therapies for Mitral Valve Disease (Mitraclip,percutaneous annuloplasty and transcatheter valve implantation) Will they reach the TAVI s success? Alec Vahanian,FESC, FRCP (Edin.) Bichat

More information

TAVR Transaortic Approach: New Trends in Aortic Valve Surgery

TAVR Transaortic Approach: New Trends in Aortic Valve Surgery : New Trends in Aortic Valve Surgery Marc R. Moon, M.D. John M. Shoenberg Chair in CV Disease Chief, Cardiac Surgery Director, Center for Diseases of the Thoracic Aorta Washington University School of

More information

Is TAVR Now Indicated in Even Low Risk Aortic Valve Disease Patients

Is TAVR Now Indicated in Even Low Risk Aortic Valve Disease Patients Is TAVR Now Indicated in Even Low Risk Aortic Valve Disease Patients Saibal Kar, MD, FACC, FAHA, FSCAI Director of Interventional Cardiac Research Cedars Sinai Heart Institute, Los Angeles, CA Potential

More information

In 2015, Cleveland Clinic cardiac and vascular

In 2015, Cleveland Clinic cardiac and vascular ERIC E. ROSELLI, MD Department of Thoracic and Cardiovascular Surgery, Heart & Vascular Institute, Cleveland Clinic Aortic replacement in cardiac surgery ABSTRACT The number of aorta procedures performed

More information

Quality Measures MIPS CV Specific

Quality Measures MIPS CV Specific Quality Measures MIPS CV Specific MEASURE NAME Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy CAHPS for MIPS Clinician/Group Survey Cardiac Rehabilitation Patient Referral from

More information

Transcatheter Aortic Valve Replacement

Transcatheter Aortic Valve Replacement Transcatheter Aortic Valve Replacement Jesse Jorgensen, MD Medical Director, Cardiac Catheterization Laboratory Greenville Health System Greenville, South Carolina, USA January 30, 2016 Aortic Stenosis

More information

Should We Reconsider using Anticoagulation for Biological Tissue Valves

Should We Reconsider using Anticoagulation for Biological Tissue Valves Should We Reconsider using Anticoagulation for Biological Tissue Valves No Disclosures Disclosures Watching grass grow Complete with audio 1 hour 8 minutes 9884 views Subclinical Leaflet Thrombosis in

More information

Evolving and Expanding Indications for TAVR

Evolving and Expanding Indications for TAVR Evolving and Expanding Indications for TAVR Wilson Y. Szeto, MD Associate Professor of Surgery Surgical Director, Transcatheter Cardio-Aortic Therapies Associate Director, Thoracic Aortic Surgery Division

More information

Cardiac Valve/Structural Therapies

Cardiac Valve/Structural Therapies Property of Dr. Chad Rammohan Cardiac Valve/Structural Therapies Chad Rammohan, MD FACC Medical Director, El Camino Hospital Cardiac Catheterization Lab Director, Interventional and Structural Cardiology,

More information

Quality ID #168 (NQF 0115): Coronary Artery Bypass Graft (CABG): Surgical Re-Exploration National Quality Strategy Domain: Effective Clinical Care

Quality ID #168 (NQF 0115): Coronary Artery Bypass Graft (CABG): Surgical Re-Exploration National Quality Strategy Domain: Effective Clinical Care Quality ID #168 (NQF 0115): Coronary Artery Bypass Graft (CABG): Surgical Re-Exploration National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE

More information

TAVR in 2020: What is Next!!!!

TAVR in 2020: What is Next!!!! TAVR in 2020: What is Next!!!! Vinod H. Thourani, MD Professor of Surgery Chairman, Department of Cardiac Surgery Medstar Heart and Vascular Institute Washington Hospital Center Washington, DC Disclosures

More information

Indication, Timing, Assessment and Update on TAVI

Indication, Timing, Assessment and Update on TAVI Indication, Timing, Assessment and Update on TAVI Swedish Heart and Vascular Institute Ming Zhang MD PhD Interventional Cardiology Structure Heart Disease Conflict of Interest None Starr- Edwards Mechanical

More information

TAVR for Valve-In-Valve. Brian O Neill Assistant Professor of Medicine Department of Medicine, Section of Cardiology

TAVR for Valve-In-Valve. Brian O Neill Assistant Professor of Medicine Department of Medicine, Section of Cardiology TAVR for Valve-In-Valve Brian O Neill Assistant Professor of Medicine Department of Medicine, Section of Cardiology Temple Hearth and Vascular Institute Disclosures: Consultant: Cardiac Assist TAVR for

More information

Aortic Stenosis: Open vs TAVR vs Nothing

Aortic Stenosis: Open vs TAVR vs Nothing Aortic Stenosis: Open vs TAVR vs Nothing Wilson Y. Szeto, MD Associate Professor of Surgery Surgical Director, Transcatheter Cardio-Aortic Therapies Associate Director, Thoracic Aortic Surgery Division

More information

TAVR IN INTERMEDIATE-RISK PATIENTS

TAVR IN INTERMEDIATE-RISK PATIENTS TAVR IN INTERMEDIATE-RISK PATIENTS K. Lampropoulos MD, PhD, FESC, MEAPCI Interventional Cardiologist Evangelismos General Hospital The Burden of Valve Disease Prevalence Survival NATURAL HISTORY OF AS

More information

Published Manuscripts Based in the STS/ACC TVT Registry

Published Manuscripts Based in the STS/ACC TVT Registry Published Manuscripts Based in the STS/ACC TVT Registry June 2018 Legend Manuscript Status is designated as follows: Abbreviations: Published/Full Citation Provided: Manuscript is in print. In Press: Manuscript

More information

YOUR CARDIOTHORACIC SURGERY TEAM

YOUR CARDIOTHORACIC SURGERY TEAM JAMES R. TAYLOR, JR., MD, Co-Director, Stony Brook Heart Institute; Chief, Division of Cardiothoracic Surgery and Professor of Surgery, is board certified in cardiothoracic and general surgery, and has

More information

Valvular heart disease (VHD) is present in 2.5% of the

Valvular heart disease (VHD) is present in 2.5% of the 2017 Focused Update for Management of Patients With Valvular Heart Disease: Summary of New Recommendations Richard Matiasz, MD; Vera H. Rigolin, MD Valvular heart disease (VHD) is present in 2.5% of the

More information

Steph ani eph ani Mi M ck i MD Cleveland Clinic

Steph ani eph ani Mi M ck i MD Cleveland Clinic Stephanie Mick MD Stephanie Mick MD Cleveland Clinic Upper hemisternotomy AVR Ascending Aorta MVr Thoracotomy Based Anterior AVR Lateral Thoracotomy Mitral/Tricuspid surgery Robotically assisted surgery

More information

How to Avoid Prosthesis-Patient Mismatch

How to Avoid Prosthesis-Patient Mismatch How to Avoid Prosthesis-Patient Mismatch Philippe Pibarot, DVM, PhD, FACC, FAHA, FASE, FESC Canada Research Chair in Valvular Heart Diseases INSTITUT UNIVERSITAIRE DE CARDIOLOGIE ET DE PNEUMOLOGIE DE QUÉBEC

More information

ACTION REGISTRY New Old ID# ID #

ACTION REGISTRY New Old ID# ID # In Process, Unpublished NCDR Manuscripts The following pages list current research and publications proposals that have been recently approved, are under analysis, are under manuscript development, or

More information

Percutaneous Aortic Valvuloplasty: Long-Term Survival

Percutaneous Aortic Valvuloplasty: Long-Term Survival Percutaneous Aortic Valvuloplasty: Long-Term Survival Angioplasty Summit Seoul April 27, 2007 James R. Margolis MD Carmen Paez MD, Kevin Coy MD, Edward Freeman PhD Miami International Cardiology Consultants

More information

Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated?

Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated? Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated? RM Suri, V Sharma, JA Dearani, HM Burkhart, RC Daly, LD Joyce, HV Schaff Division of Cardiovascular Surgery, Mayo Clinic, Rochester,

More information

Aortic Stenosis: Background

Aortic Stenosis: Background Transcatheter Aortic Valve Replacement in Low Surgical Risk Patients Barry George, MD The Ohio State University Structural Heart Disease Course May 19 th, 2017 Aortic Stenosis: Background Severe Symptomatic

More information

When Should We Consider TAVI. (Surgeon s Viewpoint)? Pyowon Park Samsung Medical Center Seoul, Korea

When Should We Consider TAVI. (Surgeon s Viewpoint)? Pyowon Park Samsung Medical Center Seoul, Korea When Should We Consider TAVI Procedure in Korea (Surgeon s Viewpoint)? Pyowon Park Samsung Medical Center Seoul, Korea Aortic Stenosis in Korea Rapidly increasing valve disease in Korea Still low incidence

More information

Valvular Heart Disease:

Valvular Heart Disease: Oklahoma Heart Institute 1120 South Utica Avenue Tulsa, OK 74104 Valvular Heart Disease: Transcatheter AorticValve Replacement (TAVR) Transcatheter Mitral Valve Repair (TMVR) Oklahoma Heart Institute Physicians

More information

Measure #164 (NQF 0129): Coronary Artery Bypass Graft (CABG): Prolonged Intubation National Quality Strategy Domain: Effective Clinical Care

Measure #164 (NQF 0129): Coronary Artery Bypass Graft (CABG): Prolonged Intubation National Quality Strategy Domain: Effective Clinical Care Measure #164 (NQF 0129): Coronary Artery Bypass Graft (CABG): Prolonged Intubation National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY DESCRIPTION:

More information

Outcomes of Surgical Aortic Valve Replacement in Moderate Risk Patients: Implications for Determination of Equipoise in the Transcatheter Era

Outcomes of Surgical Aortic Valve Replacement in Moderate Risk Patients: Implications for Determination of Equipoise in the Transcatheter Era Outcomes of Surgical Aortic Valve Replacement in Moderate Risk Patients: Implications for Determination of Equipoise in the Transcatheter Era Sebastian A. Iturra, Rakesh M. Suri, Kevin L. Greason, John

More information

Understanding the guidelines for Interventions in MR. Ali AlMasood

Understanding the guidelines for Interventions in MR. Ali AlMasood Understanding the guidelines for Interventions in MR Ali AlMasood Mitral regurgitation The most diverse from all acquired valve diseases About 50% of patients with an LVEF 35 percent had moderate to severe

More information

Cleveland Clinic Innovation Center

Cleveland Clinic Innovation Center Innovations Cleveland Clinic Innovation Center Cleveland Clinic Innovation Center (CCIC) is Cleveland Clinic s technology commercialization arm. Our mission is to benefit the sick through the broad and

More information

TAVI- Is Stroke Risk the Achilles Heel of Percutaneous Aortic Valve Repair?

TAVI- Is Stroke Risk the Achilles Heel of Percutaneous Aortic Valve Repair? TAVI- Is Stroke Risk the Achilles Heel of Percutaneous Aortic Valve Repair? Elaine E. Tseng, MD and Marlene Grenon, MD Department of Surgery Divisions of Adult Cardiothoracic and Vascular and Endovascular

More information

University of Florida Department of Surgery. CardioThoracic Surgery VA Learning Objectives

University of Florida Department of Surgery. CardioThoracic Surgery VA Learning Objectives University of Florida Department of Surgery CardioThoracic Surgery VA Learning Objectives This service performs coronary revascularization, valve replacement and lung cancer resections. There are 2 faculty

More information

YOUR CARDIOTHORACIC SURGERY TEAM

YOUR CARDIOTHORACIC SURGERY TEAM JAMES R. TAYLOR, JR., MD, Co-Director, Stony Brook Heart Institute; Chief, Division of Cardiothoracic Surgery and Professor of Surgery, is board certified in cardiothoracic and general surgery, and has

More information

Essential Support for a Structural Heart Program: The Valve and Structural Heart Clinic

Essential Support for a Structural Heart Program: The Valve and Structural Heart Clinic Essential Support for a Structural Heart Program: The Valve and Structural Heart Clinic Vincent Varghese, DO, FACC, FSCAI Director, Interventional Cardiology Fellowship Program Deborah Heart and Lung Center

More information

Is Stroke Frequency Declining?

Is Stroke Frequency Declining? Is Stroke Frequency Declining? Etiologic Factors Clinical, Anatomic, Technique-related, and Device-specific Samir Kapadia, MD Professor of Medicine Section head, Interventional Cardiology Director, Cardiac

More information

Selection of aortic valve replacement versus transcatheter aortic valve replacement in high-risk patients: a Markov model

Selection of aortic valve replacement versus transcatheter aortic valve replacement in high-risk patients: a Markov model Selection of aortic valve replacement versus transcatheter aortic valve replacement in high-risk patients: a Markov model Hemal Gada, MD, MBA and Thomas H Marwick, MD, PhD Department of Cardiovascular

More information

Percutaneous Valve in Native With and Without Mitral Valve Calcification: When To Go Hybrid

Percutaneous Valve in Native With and Without Mitral Valve Calcification: When To Go Hybrid Percutaneous Valve in Native With and Without Mitral Valve Calcification: When To Go Hybrid Deborah Tabachnick, MD Cardiac Surgeon The Heart Hospital Baylor Plano Baylor Scott & White Health Disclosures

More information

Carpentier-Edwards Pericardial Valve in the Aortic Position: 25-Years Experience

Carpentier-Edwards Pericardial Valve in the Aortic Position: 25-Years Experience SURGERY: The Annals of Thoracic Surgery CME Program is located online at http://www.annalsthoracicsurgery.org/cme/ home. To take the CME activity related to this article, you must have either an STS member

More information

Incorporating the intermediate risk in Transcatheter Aortic Valve Implantation (TAVI)

Incorporating the intermediate risk in Transcatheter Aortic Valve Implantation (TAVI) Incorporating the intermediate risk in Transcatheter Aortic Valve Implantation (TAVI) Larry S. Dean, MD, MSCAI Past President SCAI Professor of Medicine and Surgery University of Washington School of Medicine

More information

Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat

Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat Innovative Procedures, Devices & State of the Art Care for Arrhythmias, Heart Failure & Structural Heart Disease October 8-10,

More information

Peripheral and Cardiology Coder 2018

Peripheral and Cardiology Coder 2018 Peripheral and Cardiology Coder 2018 Cardiovascular Services and Procedures Prepared and Published By: MedLearn Publishing A Division of MedLearn Media, Inc. 445 Minnesota Street, Suite 514 St. Paul, MN

More information

Next Generation Therapies: Aortic, Mitral and Beyond

Next Generation Therapies: Aortic, Mitral and Beyond Next Generation Therapies: Aortic, Mitral and Beyond Scott M Lilly, MD PhD Medical (Interventional) Director, Structural Heart Program Heart Summit, Lima OH August 26 th, 2017 Next Generation Therapies:

More information

Culprit vs Multivalve Transcatheter Intervention

Culprit vs Multivalve Transcatheter Intervention Culprit vs Multivalve Transcatheter Intervention Howard C. Herrmann, MD, FACC, MSCAI John Bryfogle Professor of Cardiovascular Medicine and Surgery Health System Director for Interventional Cardiology

More information